跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
cathelicidin
首页
药物
cathelicidin
cathelicidin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Use of the cathelicidin ll-37 and dervicaties thereof for would healing
US 2007149448 A1
申请人: STAHLE-BACKDAHL MONA
优先权: 2003
CN
US
13 件公开
Prevention of rosacea inflammation
US 9801848 B2
申请人: UNIV CALIFORNIA
优先权: 2013
US
WO
9 件公开
Disease treatment via antimicrobial peptides or their inhibitors
US 8202835 B2
申请人: HILLMAN YITZCHAK
优先权: 2008
US
4 件公开
EP 2200628 A2
申请人: HILLMAN YITZCHAK
优先权: 2007
EP
WO
2 件公开
US 9044438 B2
申请人: HILLMAN YITZCHAK
优先权: 2012
US
2 件公开
US 2014235544 A1
申请人: HILLMAN YITZCHAK
优先权: 2013
US
VACCINE ADJUVANTS
EP 4709394 A2
申请人: SEQIRUS INC
优先权: 2023
CN
EP
WO
3 件公开
COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING CHRONIC KIDNEY DISEASE
EP 4754532 A1
申请人: NESTLE SA
优先权: 2023
EP
US
WO
3 件公开
Human cathelicidin antimicrobial peptides
US 2007037744 A1
申请人: UNIV CALIFORNIA
优先权: 2003
CN
US
3 件公开
US 2007065908 A1
申请人: UNIV CALIFORNIA
优先权: 2004
US
2 件公开
Antimicrobial cathelicidin peptides
US 7985832 B2
申请人: UNIV KANSAS STATE
优先权: 2005
CN
US
3 件公开
NEW MEDICAL PRODUCTS
US 2010178320 A1
申请人: LIPOPEPTIDE AB
优先权: 2008
CN
US
3 件公开
Method of preventing or treating pancreatic dysfunction or diabetes by upregulating human cathelicidin LL-37 to inhibit islet amyloid polypeptide (IAPP) self-assembly
US 12685490 B2
申请人: UNIV LELAND STANFORD JUNIOR
优先权: 2020
US
WO
3 件公开
METHOD OF VACCINATION COMPRISING ADMINISTERING AN ANTIGEN AND A CATHELICIDIN DERIVED ANTIMICROBIAL PEPTIDE
US 2008166368 A1
申请人: INTERCELL AG
优先权: 2000
US
3 件公开
第 1 / 9 页
上一页
下一页
药物
反馈